Simrat Randhawa sold $2.4M of Dianthus Therapeutics (DNTH)

Executed Jun 1, disclosed Jun 2, 1 day later.

Value, as filed

$2.4M

26,530 sh across 3 lots

Executed

Jun 1

the trade date, as filed

Disclosed

Jun 2

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Simrat Randhawa EVP, Head of R&D profile →

Simrat Randhawa (EVP, Head of R&D) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Dianthus Therapeutics, Inc. (DNTH). The largest single filing was $7.4M of DNTH (196,538 sh across 4 lots, as filed), executed Nov 13 2025.

The name

DNTH

Dianthus Therapeutics, Inc. DNTH · Healthcare · 18 filings in 24 months ticker →

Healthcare · Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoi…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Simrat Randhawa in DNTH

DNTHSALE Dianthus Therapeutics, Inc. $2.5M
23,124 sh across 3 lots
Exec Sep 1
Filed Sep 3 · 4:30 PM ET DNTHSALE Dianthus Therapeutics, Inc. $2.8M
33,830 sh × $81.48
Exec Mar 12
Filed Mar 13 · 5:30 PM ET DNTHSALE Dianthus Therapeutics, Inc. $7.4M
196,538 sh across 4 lots
Exec Nov 13 2025
Filed Nov 14 2025 · 5:30 PM ET